(Q39647591)

13 September 2017

title

Evaluation of the measles, mumps and rubella immunisation programme in Spain by using a sero-epidemiological survey (English)

1 reference

13 September 2017

1 reference

1 reference

1 reference

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12705626

26 December 2023

author name string

C. Amela

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12705626

26 December 2023

I. Pachón

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12705626

26 December 2023

F. de Ory

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12705626

26 December 2023

language of work or name

1 reference

1 January 2003

1 reference

European Journal of Epidemiology

13 September 2017

published in

1 reference

13 September 2017

volume

18

1 reference

13 September 2017

issue

1

1 reference

13 September 2017

page(s)

71-79

1 reference

https://scigraph.springernature.com/pub.10.1023/a:1022567811765

13 September 2017

exact match

0 references

cites work

Cellular Immunity in Measles Vaccine Failure: Demonstration of Measles Antigen-Specific Lymphoproliferative Responses despite Limited Serum Antibody Production after Revaccination

1 reference

12 December 2020

Assessing vaccine efficacy in the field. Further observations

1 reference

12 December 2020

Inadequate immunity to measles in children vaccinated at an early age: effect of revaccination

1 reference

12 December 2020

Measles vaccine efficacy during an outbreak in a highly vaccinated population: Incremental increase in protection with age at vaccination up to 18 months

1 reference

12 December 2020

Immunosurveillance and the evaluation of national immunization programmes: a population-based approach

1 reference

12 December 2020

Persistence of anti-mumps virus antibodies after a two-dose MMR vaccination. A nine-year follow-up

1 reference

12 December 2020

Mumps outbreak in a highly vaccinated population

1 reference

12 December 2020

The efficiency of measles and pertussis notification in England and Wales.

1 reference

12 December 2020

Mumps and mumps vaccine: a global review

1 reference

12 December 2020

An outbreak of mumps in a population partially vaccinated with the Rubini strain

1 reference

12 December 2020

Health 21: The health for all policy framework for the WHO European Region

1 reference

12 December 2020

Two outbreaks of mumps in children vaccinated with the Rubini strain in Spain indicate low vaccine efficacy

1 reference

12 December 2020

Two doses of MMR vaccine--sufficient to eradicate measles, mumps and rubella?

1 reference

12 December 2020

Clinical efficacy of measles vaccine during the 1990 measles epidemic

1 reference

12 December 2020

Outbreak of mumps associated with poor vaccine efficacy - Oporto Portugal 1996.

1 reference

12 December 2020

Effectiveness of mumps vaccine in a school outbreak

1 reference

12 December 2020

The estimation of age-related rates of infection from case notifications and serological data

1 reference

12 December 2020

The epidemiology of measles in Poland: prevalence of measles virus antibodies in the population

1 reference

12 December 2020

Control of rubella and congenital rubella syndrome (CRS) in developing countries, Part 1: Burden of disease from CRS.

1 reference

12 December 2020

Ten years of serological surveillance in England and Wales: methods, results, implications and action.

1 reference

12 December 2020

Identifiers

DOI

10.1023/A:1022567811765

1 reference

Dimensions Publication ID

13 September 2017

1035267234

0 references

1 reference